According to the research report titled ‘Global Drug Abuse Testing Market Size study, by Product & Services (Analyzers, Rapid Testing Devices, Consumables, and Laboratory Services), By Sample Type (Urine, Oral Fluid, Breath, Hair, and Others), By End-User (Workplaces & Schools, Criminal Justice Systems & Law Enforcement Agencies, Research Laboratories, and Hospitals), and Regional Forecasts 2020-2027’, available with Market Study Report, global drug abuse testing market is projected to record a robust y-o-y growth rate during 2020-2027.
 

Mounting number of individuals consuming alcohol and illegal substances like methamphetamine, tobacco, and others, along with stringent government regulations, and technological advancements in testing devices are the key factors propelling global drug abuse testing market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2790678/
 

Notably, over the past five years, clinical procedures for tracking drug testing have undergone major changes to keep up with the rapid rise in drug exploitation, emergence of new addictive substances, surging customer demands, and higher substitution matrices.
 

For those unversed, drug addiction monitoring is a non-invasive clinical analysis of biological products, such as semen, saliva, skin, and others, in order to identify the presence of illegal, addictive drugs or metabolites. The most preferred method of analysis used for drug abuse testing is urine samples. Drug monitoring is a critical add-on to health care and drug usage, and is employed for businesses, sporting clubs, medical uses, and other such applications.
 

The uptrend observed in worldwide drug abuse testing industry is due to major players expanding their product range to maintain their expertise and revenue stake by integrating products and updating applications with different drug abuse testing substances.
 

Citing an instance, in August 2016, Thermo Fisher Scientific received 510 (k) approval from the U.S. FDA for the DRI Hydrocodone Assay. The test detects hydrocodone, the most widely used and misused opiate drug in the United States.
 

On the downside, lack of awareness and acceptance of substance monitoring as a breach of privacy rights in some countries, however, restricts the expansion of worldwide drug abuse testing industry size.
 

Speaking of the geographical ambit, North America drug abuse testing industry is expected to grow substantially through 2027, attributable to increasing use of illegal narcotics. Moreover, various initiatives by the U.S. government to reduce drug abuse cases, including mandatory drug testing in various departments, like mining, oil & gas, defense, and Department of Transportation (DOT), are also contributing to the regional market outlook.
 

Renowned companies in worldwide drug abuse testing market sphere are Express Diagnostics International Inc., Quest Diagnostics Incorporated, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens AG, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, and Draegerwerk AG & Co. KGaA.